Center for Biomaterials, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology (UST), Seoul, 02792, Republic of Korea.
Tissue Eng Regen Med. 2022 Jun;19(3):617-628. doi: 10.1007/s13770-021-00414-4. Epub 2021 Dec 28.
Macrophages, with many different phenotypes play a major role during wound healing process, secreting the cytokines crucial to angiogenesis, cell recruitment and ECM remodeling. Therefore, macrophage-derived cytokines may be attractive therapeutic resource for wound healing.
To obtain a conditioned media (CM) from macrophages, human monocyte THP-1 cells were seeded on TCP or human fibroblast-derived matrix (hFDM) and they were differentiated into M1 or M2 phenotype using distinct protocols. A combination of different substrates and macrophage phenotypes produced M1- and M2-CM or M1-hFDM- and M2-hFDM-CM, respectively. Proteome microarray determines the cytokine contents in those CMs. CMs-treated human dermal fibroblast (hDFB) was analyzed using collagen synthesis and wound scratch assay. Concentrated form of the CM (CCM), obtained by high-speed centrifugation, was administered to a murine full-thickness wound model using alginate patch, where alginate patch was incubated in the M2-CCM overnight at 4 °C before transplantation. On 14 day post-treatment, examination was carried out through H&E and Herovici staining. Keratinocyte and M2 macrophages were also evaluated via immunofluorescence staining.
Cytokine analysis of CMs found CCL1, CCL5, and G-CSF, where CCL5 is more dominant. We found increased collagen synthesis and faster wound closure in hDFB treated with M2-CM. Full-thickness wounds treated by M2-hFDM-CCM containing alginate patch showed early wound closure, larger blood vessels, increased mature collagen deposition, enhanced keratinocyte maturation and more M2-macrophage population.
Our study demonstrated therapeutic potential of the CM derived from M2 macrophages, where the cytokines in the CM may have played an active role for enhanced wound healing.
巨噬细胞具有多种不同表型,在伤口愈合过程中发挥重要作用,分泌对血管生成、细胞招募和 ECM 重塑至关重要的细胞因子。因此,巨噬细胞衍生的细胞因子可能是伤口愈合的有吸引力的治疗资源。
为了从巨噬细胞中获得条件培养基 (CM),将人单核细胞 THP-1 细胞接种在 TCP 或人成纤维细胞衍生基质 (hFDM) 上,并使用不同的方案将其分化为 M1 或 M2 表型。不同的基质和巨噬细胞表型的组合分别产生 M1- 和 M2-CM 或 M1-hFDM- 和 M2-hFDM-CM。蛋白质组芯片确定了这些 CM 中的细胞因子含量。用胶原合成和划痕实验分析 CM 处理的人真皮成纤维细胞 (hDFB)。通过高速离心获得浓缩形式的 CM (CCM),并用藻酸盐贴片施用于鼠全层伤口模型,其中在移植前将藻酸盐贴片在 4°C 下在 M2-CCM 中孵育过夜。在治疗后 14 天,通过 H&E 和 Herovici 染色进行检查。通过免疫荧光染色还评估了角质形成细胞和 M2 巨噬细胞。
对 CMs 的细胞因子分析发现 CCL1、CCL5 和 G-CSF,其中 CCL5 更为突出。我们发现用 M2-CM 处理的 hDFB 中胶原合成增加且伤口愈合更快。含有藻酸盐贴片的 M2-hFDM-CCM 处理的全层伤口显示出早期伤口闭合、更大的血管、增加的成熟胶原沉积、增强的角质形成细胞成熟和更多的 M2 巨噬细胞群。
我们的研究表明,M2 巨噬细胞衍生的 CM 具有治疗潜力,其中 CM 中的细胞因子可能在增强伤口愈合方面发挥了积极作用。